You are here

  • Home
  • Archive
  • Volume 10, Issue 7
  • Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors

 

Online download statistics by month:

Online download statistics by month: July 2022 to September 2025

AbstractFullPdf
Jul 2022810833186
Aug 2022887916346
Sep 2022410427238
Oct 2022342349147
Nov 2022251260101
Dec 202215816141
Jan 202326526778
Feb 202319921098
Mar 202319720383
Apr 202318118471
May 202317417757
Jun 202313613851
Jul 2023979940
Aug 2023949631
Sep 20239810047
Oct 202310110667
Nov 2023979741
Dec 2023808034
Jan 2024747554
Feb 2024808055
Mar 202414414686
Apr 202412312467
May 202421321344
Jun 2024127128124
Jul 2024919433
Aug 2024959436
Sep 2024717430
Oct 2024869354
Nov 202410310654
Dec 2024888944
Jan 202510410444
Feb 202526526548
Mar 2025727436
Apr 2025949553
May 202512312751
Jun 2025565738
Jul 2025110
Aug 2025110
Sep 2025110
Total658967442708